Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04466228 · ClinicalTrials.gov registry record · NA
Non-invasive Transcranial Electrical Stimulation in MS
A NA study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT04466228: Completed NA study, sponsored by University of California, San Francisco.
NCT04466228 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 60 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04466228, a NA study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
The goal is to investigate the effects of non-invasive transcranial electrical stimulation on cognition in MS.
Primary Outcome
Symbol Digit Modalities Test (SDMT) score will be used to measure processing speed. SDMT measures the time to pair abstract symbols with specific numbers. The test requires visuoperceptual processing, working memory, and psychomotor speed. The score is the number of correctly coded items in 90 seconds. (max=110, min=0). Higher scores indicate improvement. Lower scores indicate worsening.
Interventions
- DEVICE non-invasive transcranial electrical stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2020-10-16 |
| Est. Completion | 2022-08-23 |
| Phase | NA |
What the finished NCT04466228 record still lists
NCT04466228 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 1 intervention - of which non-invasive transcranial electrical stimulation is the first listed.
NCT04466228 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04466228 about?
NCT04466228 is a clinical study titled "Non-invasive Transcranial Electrical Stimulation in MS". The goal is to investigate the effects of non-invasive transcranial electrical stimulation on cognition in MS.
What is the current status of trial NCT04466228?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2020-10-16. Estimated completion is 2022-08-23.
What interventions are being tested in trial NCT04466228?
The interventions under investigation include: non-invasive transcranial electrical stimulation (DEVICE).
Who is sponsoring clinical trial NCT04466228?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04466228's enrollment target sits among peer trials
60 1164th of 2000 higher than 745 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI